Angus C. Russell Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Angus C. Russell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Angus C. Russell. Angus C. Russell is a Director in TherapeuticsMD, Inc. ($COFF) and a Director in BIOTIME INC ($BTX) and a Director in Revance Therapeutics, Inc. ($RVNC) and a Director in Mallinckrodt plc ($MNK).
Address: C/O INTERMUNE, INC. 3280 BAYSHORE BOULEVARD BRISBANE 94005 CA
Companies in which Angus C. Russell is an Insider
Lineage Cell Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Angus C. Russell: Director
Holdings: 67,500 shares
Current Value: $206,550
Latest Transaction: Jul 02 2020
$BTX Market Capitalization: $309.34M
$BTX Previous Close: $3.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mallinckrodt plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Angus C. Russell: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 16 2020
$MNK Market Capitalization: $5.32B
$MNK Previous Close: $50.68
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Revance Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Angus C. Russell: Director
Holdings: 20,513 shares
Current Value: $424,619
Latest Transaction: May 07 2021
$RVNC Market Capitalization: $591.69M
$RVNC Previous Close: $20.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TherapeuticsMD, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Angus C. Russell: Director
Holdings: 93,500 shares
Latest Transaction: Jun 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Angus C. Russell
Sentiment: All, BTX, MNK, RVNC, TXMD
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 27.91 | 7,551 | 210,748 | 7,551 | |
| May 07 2021 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Grant | A | 0.00 | 4,013 | 0 | 20,513 | 16.5 K to 20.5 K (+24.32 %) |
| Nov 16 2020 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Sell | S | 0.13 | 51,789 | 6,665 | 0 | 51.8 K to 0 (-100.00 %) |
| Jul 02 2020 | BTX | Lineage Cell Thera ... | Russell Angus C. | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
| May 15 2020 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 19.40 | 12,000 | 232,800 | 12,000 | |
| May 15 2020 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Grant | A | 0.00 | 6,000 | 0 | 16,500 | 10.5 K to 16.5 K (+57.14 %) |